{
    "organizations": [],
    "uuid": "25e4efe2db1626f043dfb20e14220dde17bb81bc",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-indias-aurobindo-pharma-dec-qtr-co/brief-indias-aurobindo-pharma-dec-qtr-consol-net-profit-rises-about-3-pct-idUSFWN1PX11D",
    "ord_in_thread": 0,
    "title": "BRIEF-India's Aurobindo Pharma Dec-Qtr Consol Net Profit Rises About 3 Pct",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 7 (Reuters) - Aurobindo Pharma Ltd:\n* DEC QUARTER CONSOL NET PROFIT 5.95 BILLION RUPEES VERSUS 5.79 BILLION RUPEES LAST YEAR\n* CONSENSUS FORECAST FOR DEC QUARTER CONSOL NET PROFIT WAS 6.71 BILLION RUPEES\n* DEC QUARTER CONSOL NET SALES 42.69 BILLION RUPEES VERSUS 38.44 BILLION RUPEES LAST YEAR Source text: bit.ly/2BhpC5Y Further company coverage:\n ",
    "published": "2018-02-07T20:11:00.000+02:00",
    "crawled": "2018-02-09T05:49:31.012+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "aurobindo",
        "pharma",
        "ltd",
        "dec",
        "quarter",
        "consol",
        "net",
        "profit",
        "billion",
        "rupee",
        "versus",
        "billion",
        "rupee",
        "last",
        "year",
        "consensus",
        "forecast",
        "dec",
        "quarter",
        "consol",
        "net",
        "profit",
        "billion",
        "rupee",
        "dec",
        "quarter",
        "consol",
        "net",
        "sale",
        "billion",
        "rupee",
        "versus",
        "billion",
        "rupee",
        "last",
        "year",
        "source",
        "text",
        "company",
        "coverage"
    ]
}